Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 15551 - 15575 of 15679 in total
Tmi 005 is under investigation in clinical trial NCT00095342 (Study Evaluating TMI-005 in Active Rheumatoid Arthritis).
Investigational
Matched Iupac: … (3S)-N-hydroxy-4-{4-[(4-hydroxybut-2-yn-1-yl)oxy]benzenesulfonyl}-2,2-dimethylthiomorpholine-3-carboxamide …
Experimental
Matched Iupac: … 3-(pyridine-3-carbonyloxy)propyl 2-(4-chlorophenoxy)-2-methylpropanoate …
Experimental
Illicit
Experimental
Experimental
Experimental
Matched Iupac: … 2-(3-methoxyphenyl)-1,1-dioxo-2H,3H,4H-1lambda6-thieno[3,2-e][1,2]thiazine-6-sulfonamide …
Experimental
Matched Iupac: … (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorobenzenesulfonyl)-2-hydroxy-2-methylpropanamide …
Experimental
Matched Iupac: … 2-(4-fluorophenyl)ethan-1-ol …
Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn
Experimental
Matched Iupac: … {[2-(4-iodophenyl)acetamido]methyl}phosphinic acid …
Investigational
Experimental
Matched Iupac: … 2,2-dibromo-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide …
Experimental
Matched Iupac: … 1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}urea …
Displaying drugs 15551 - 15575 of 15679 in total